VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces the completion of all validation and verification of the chemiluminescent immunoassay (ChLIA) version of its ...
GAAP net combined ratio in the quarter, with a 75% full-year ratio, driven by a 1.2-point catastrophe loss ratio, materially lower than the six-year average of 7.1 points. Net Premiums Earned -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results